NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹395 Cr | ₹365 Cr | ₹262 Cr | ₹216 Cr | ₹194 Cr |
What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹395 Cr |
| Mar2025 | ₹365 Cr |
| Mar2024 | ₹262 Cr |
| Mar2023 | ₹216 Cr |
| Mar2022 | ₹194 Cr |
How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹395 Cr | 8.05 | |
| Mar2025 | ₹365 Cr | 39.19 | |
| Mar2024 | ₹262 Cr | 21.26 | |
| Mar2023 | ₹216 Cr | 11.40 | |
| Mar2022 | ₹194 Cr | - | |
Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹257.4 Cr | -3.1% | -11.2% | -16.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,496.6 Cr | -5% | -7.3% | -32.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,266.7 Cr | 0.2% | -2.2% | 11% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,300.8 Cr | -2.8% | -5.4% | 21.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹824.5 Cr | -7.6% | -15.5% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹520.4 Cr | 2.9% | -0.5% | -9.1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3.1% |
-11.2% |
-16.8% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses